Systems performance and glucose control with the Medtronic advanced hybrid closed loop system (A-HCL) using insulin aspart vs faster acting insulin aspart (FiASP): Extension study evaluating meal-time glucose control
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Medtronics
Most Recent Events
- 16 Jun 2020 Results assessing postprandial glucose (PPG) in Type 1 diabetes patients through time-block data presented at the 80th Annual Scientific Sessions of the American Diabetes Association
- 16 Jun 2020 Status changed to recruiting, according to results presented at the 80th Annual Scientific Sessions of the American Diabetes Association
- 09 Oct 2019 New trial record